Additional Information

Description

Tazicef 2 gm Vial is a broad-spectrum intravenous antibiotic used to treat a variety of bacterial infections. It contains cefoperazone, a third-generation cephalosporin antibiotic, which works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death. The 2 gm vial formulation is typically for infections caused by susceptible organisms, such as respiratory tract infections, urinary tract infections, and intra-abdominal infections.

Cefoperazone has a wide range of activity against both Gram-positive and Gram-negative bacteria, making it an effective treatment option for serious infections. It is particularly useful for patients who require intravenous therapy due to the severity or location of the infection. The drug is administered via injection or infusion, allowing for rapid delivery to the bloodstream, where it can exert its therapeutic effects.

The dosage of Tazicef 2 gm Vial is determined by the severity of the infection and the patient's clinical response. Like other cephalosporins, cefoperazone is generally well tolerated but may cause side effects such as gastrointestinal disturbances, allergic reactions, or changes in liver function. It is contraindicated in patients with a known allergy to cephalosporins or penicillins.